- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04943237
Anti-TNF Therapy and Nerve Conduction Studies in Ankylosing Spondylitis
Anti-TNF Therapy and Nerve Conduction Studies in Patients With Ankylosing Spondylitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Demyelinating lesions in central nervous system after anti-TNF agents were reported previously. There are limited studies investigating the effects of anti-TNF treatments on the peripheral nervous system. The aim of this study is to investigate whether peripheral nerves are affected due to long-term use of anti-TNF agents.
Patients with a diagnosis of ankylosing spondylitis who received conventional or anti-TNF therapy for five years at Istanbul Physical Therapy and Rehabilitation Training and Research Hospital were included in the study. The patients were divided into two groups as conventional group and anti-TNF group according to the treatment they received. All patients were evaluated in a single section. Sociodemographic characteristics of the patients and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functionality Index (BASFI) and Bath Ankylosing Spondylitis Metrology Index (BASMI) scores were recorded. Median-ulnar motor and sensory conduction studies and tibial-peroneal motor and sural nerve sensory conduction studies were performed in both upper extremities of all patients. Median, ulnar, and tibial nerve F-response studies were also performed.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Istanbul Physical Medicine and Rehabilitation Training and research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- Patients diagnosed with ankylosing spondylitis
- Patients who have been using conventional therapy (non-steroidal anti-inflammatory drugs and/or salazopyrin) or anti-TNF therapy for more than 5 years.
Exclusion criteria:
- Patients with rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus ......)
- Patients with other systemic diseases that can lead to neuropathy
- Patients who have had a known neuropathy or have taken medication that can lead to neuropathy as a side effect
- Patients with pacemakers
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
nerve conduction studies
Time Frame: All patients were evaluated in one session. The assesment of a patient lasted nearly 45-60 minutes
|
The evaluation of median, ulnar, tibial, peroneal and sural nerves
|
All patients were evaluated in one session. The assesment of a patient lasted nearly 45-60 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Betül Yavuz Keleş, MD, Istanbul Physical Medicine and Rehabilitation Training and research Hospital
- Study Director: Ayşe Nur Bardak, prof, Istanbul Physical Medicine and Rehabilitation Training and research Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Infections
- Joint Diseases
- Musculoskeletal Diseases
- Arthritis
- Spinal Diseases
- Bone Diseases
- Spondylarthropathies
- Bone Diseases, Infectious
- Ankylosis
- Spondylitis
- Spondylarthritis
- Spondylitis, Ankylosing
- Physiological Effects of Drugs
- Anti-Infective Agents
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Antirheumatic Agents
- Gastrointestinal Agents
- Anti-Inflammatory Agents
- Sulfasalazine
Other Study ID Numbers
- IstPMRTRHatncsias
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuropathy
-
Arash Asher, MDVoxxLifeRecruitingNeuropathy | Chemotherapy-induced Peripheral Neuropathy | Neuropathy;PeripheralUnited States
-
Henry Ford Health SystemOctapharma USA, Inc.RecruitingSmall Fiber Neuropathy | Autoimmune Small Fiber Neuropathy | Inflammatory Polyneuropathy | Immune-Mediated NeuropathyUnited States
-
Nihon Pharmaceutical Co., LtdCompletedMultifocal Motor NeuropathyJapan
-
University of AarhusCompletedMultifocal Motor NeuropathyDenmark
-
Beth Israel Deaconess Medical CenterPhoenix Neurological Associates, LTDCompletedSmall Fiber Neuropathy | Idiopathic Peripheral NeuropathyUnited States
-
Tanta UniversityCompletedDiabetic Neuropathies | Diabetic Peripheral Neuropathy | Painful Diabetic Neuropathy | Autonomic Neuropathy | Diabetic Polyneuropathy | Small Fiber NeuropathyEgypt
-
Yung-Tsan WuCompleted
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Sorlandet Hospital HFOslo University Hospital; University Hospital of North Norway; University Hospital...Not yet recruitingSmall Fiber Neuropathy | Sensory Neuropathy
-
Tri-Service General HospitalCompleted
Clinical Trials on Anti-TNF agents
-
PfizerCompleted
-
PfizerCompleted
-
HaEmek Medical Center, IsraelUniversity of Toronto; Mount Sinai Hospital, CanadaCompletedUlcerative Colitis | Anti TNF Therapy | Ileal Pouch Anal Anastomosis (IPAA)
-
TakedaCompletedInflammatory Bowel Diseases | Crohn Disease | Colitis, UlcerativeChina, Korea, Republic of, Taiwan, Russian Federation, Turkey, Argentina, Colombia, Mexico, Saudi Arabia, Singapore
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Idiopathic ArthritisUnited States
-
Universidade Federal do Rio de JaneiroUnknownArthritis | Psoriatic ArthritisBrazil
-
Janssen Biotech, Inc.Completed
-
Hospital Universitari Vall d'Hebron Research InstituteUCB PharmaUnknownRheumatoid ArthritisSpain
-
Opal Rheumatology Ltd.Merck Sharp & Dohme LLCUnknownRheumatoid Arthritis | Psoriatic Arthritis | Ankylosing SpondylitisAustralia